The US Forecaster’s Check List for Japan: A World of Difference
Expanding the valuation of a biopharmaceutical asset to Japan requires a new mindset in nearly every input of forecasting, with many pitfalls.
At the 2021 Intellus Worldwide Institute conference on September 23, 2021, Doug Willson, Senior Vice President, Cello Health Advantage, shared a checklist to improve the rigor and validity of product forecasts for Japan.
Read our interview on Alzheimer’s and dementia with Dr. Ashby, who leads a research group within the School of Physiology, Pharmacology and Neuroscience at the University of Bristol by completing the form below.
Cello Health has developed a suite of syndicated offerings tailored to support your strategic objectives at key stages in the product lifecycle. Our customizable group of reports will provide regular actionable insights from market landscape maps based on social media data, as well as ongoing tracking of HCP preferences and channel behavior.
Using organic and unfiltered social media data, Cello Health is proud to share with you the first in a series of reports aimed at centralizing and amplifying the authentic patient experience.
The journey to scientific and commercial success is often complex and always critical, if you are looking for an expert partner to help steer you to confident solutions, contact us todayContact us